Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Study to Evaluate the Efficacy and Safety of Adoptive Transfer of Autologous Tumor Infiltrating Lymphocytes in Patients With Unresectable, Recurrent, or Metastatic Gastrointestinal Stromal Tumors

NCT07647068 is registered in ClinicalTrials.gov with Joal Beane as lead sponsor.

NCT NCT07647068
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07647068 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Study to Evaluate the Efficacy and Safety of Adoptive Transfer of Autologous Tumor Infiltrating Lymphocytes in Patients With Unresectable, Recurrent, or Metastatic Gastrointestinal Stromal Tumors
Lead sponsor
Joal Beane
Phase
Phase 2
Overall status
Not yet recruiting
Start date
February 15, 2027
Completion date
December 31, 2027
Enrollment
59 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced gastrointestinal stromal tumor, metastatic gastrointestinal stromal tumor, recurrent gastrointestinal stromal tumor, refractory malignant gastrointestinal stromal tumor, unresectable malignant gastrointestinal stromal tumor